Literature DB >> 12378407

Establishment of an oriP/EBNA1-based episomal vector transcribing human genomic beta-globin in cultured murine fibroblasts.

J Black1, J-M Vos.   

Abstract

A novel oriP/EBNA1-based episomal vector has been constructed that persists episomally in cultured murine fibroblasts. The vector, pBH148, is equipped with the entire 185-kb human beta-globin gene locus. After amplification in bacteria, column-purified episomal pBH148 was transfected into both cultured EBNA1-expressing human D98/Raji positive control fusion cells (DRpBH148) and cultured EBNA1-negative murine fibroblast cells (A9pBH148). Cell cultures were maintained concurrently with and without hygromycin selection for a period of 3 months. We show long-term stable episome maintenance of the full-size 200-kb circular double-stranded pBH148 in both the DRpBH148 cultures and the A9pBH148 cultures, regardless of selective pressure by agarose gel electrophoresis and Southern blot. EBNA1 transgene was detected by PCR in all transfected cultures. In addition, we were able to detect correctly spliced human beta-globin mRNA by RT-PCR in all transfected late-passage DRpBH148 and A9pBH148 cell cultures. These findings illustrate that this oriP/EBNA1-based episomal vector is stable in a previously nonpermissive murine cell line and is a potential vector for human gene therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12378407     DOI: 10.1038/sj.gt.3301808

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  14 in total

Review 1.  The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Mary E Ballestas; Kenneth M Kaye
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

2.  An arrayed human genomic library constructed in the PAC shuttle vector pJCPAC-Mam2 for genome-wide association studies and gene therapy.

Authors:  John Fuesler; Yasunori Nagahama; Joseph Szulewski; Joshua Mundorff; Stephanie Bireley; Jonathon S Coren
Journal:  Gene       Date:  2012-01-24       Impact factor: 3.688

Review 3.  Plasmid engineering for controlled and sustained gene expression for nonviral gene therapy.

Authors:  Ethlinn V B van Gaal; Wim E Hennink; Daan J A Crommelin; Enrico Mastrobattista
Journal:  Pharm Res       Date:  2006-05-26       Impact factor: 4.200

Review 4.  Human artificial chromosomes for gene delivery and the development of animal models.

Authors:  Yasuhiro Kazuki; Mitsuo Oshimura
Journal:  Mol Ther       Date:  2011-07-12       Impact factor: 11.454

5.  Bacterial artificial chromosomes establish replication timing and sub-nuclear compartment de novo as extra-chromosomal vectors.

Authors:  Jiao Sima; Daniel A Bartlett; Molly R Gordon; David M Gilbert
Journal:  Nucleic Acids Res       Date:  2018-02-28       Impact factor: 16.971

6.  Herpes simplex virus type 1/adeno-associated virus hybrid vectors.

Authors:  Anna Paula de Oliveira; Cornel Fraefel
Journal:  Open Virol J       Date:  2010-06-18

7.  Development of a hybrid baculoviral vector for sustained transgene expression.

Authors:  Wen-Hsin Lo; Shiaw-Min Hwang; Ching-Kuang Chuang; Chi-Yuan Chen; Yu-Chen Hu
Journal:  Mol Ther       Date:  2009-02-24       Impact factor: 11.454

8.  Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cells.

Authors:  Oliver Dorigo; Jose S Gil; Sean D Gallaher; Brenton T Tan; Maria G Castro; Pedro R Lowenstein; Michele P Calos; Arnold J Berk
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  Feline neural progenitor cells II: use of novel plasmid vector and hybrid promoter to drive expression of glial cell line-derived neurotrophic factor transgene.

Authors:  X Joann You; Jing Yang; Ping Gu; Chee Gee Liew; Henry J Klassen
Journal:  Stem Cells Int       Date:  2012-03-20       Impact factor: 5.443

10.  3D-organoid culture supports differentiation of human CAR+ iPSCs into highly functional CAR T cells.

Authors:  Zhiqiang Wang; Helen P McWilliams-Koeppen; Hernan Reza; Julie R Ostberg; Wuyang Chen; Xiuli Wang; Christian Huynh; Vibhuti Vyas; Wen-Chung Chang; Renate Starr; Jamie R Wagner; Brenda Aguilar; Xin Yang; Xiwei Wu; Jinhui Wang; Wei Chen; Ellery Koelker-Wolfe; Christopher S Seet; Amélie Montel-Hagen; Gay M Crooks; Stephen J Forman; Christine E Brown
Journal:  Cell Stem Cell       Date:  2022-03-11       Impact factor: 25.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.